1. Home
  2. CRNX vs FIZZ Comparison

CRNX vs FIZZ Comparison

Compare CRNX & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$83.99

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo National Beverage Corp.

FIZZ

National Beverage Corp.

HOLD

Current Price

$31.60

Market Cap

3.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
FIZZ
Founded
2008
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.3B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
CRNX
FIZZ
Price
$83.99
$31.60
Analyst Decision
Strong Buy
Strong Sell
Analyst Count
8
1
Target Price
$76.75
$35.00
AVG Volume (30 Days)
6.8M
537.7K
Earning Date
05-07-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.96
Revenue
$1,039,000.00
$1,180,552,000.00
Revenue This Year
$720.10
$0.14
Revenue Next Year
$184.67
$3.33
P/E Ratio
N/A
$16.09
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$30.01
52 Week High
$84.00
$46.99

Technical Indicators

Market Signals
Indicator
CRNX
FIZZ
Relative Strength Index (RSI) 90.37 44.79
Support Level $43.40 $30.51
Resistance Level $84.00 $35.84
Average True Range (ATR) 0.19 0.96
MACD -1.64 0.16
Stochastic Oscillator 71.70 45.38

Price Performance

Historical Comparison
CRNX
FIZZ

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

Share on Social Networks: